Senior Oncology Account Manager (Long Island)

About the Company

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been accepted by the U.S. FDA; IM-1021, a clinical-stage ROR1 ADC; IM-1617, a clinical-stage solid tumor ADC; and IM-3050, a clinical-stage FAP-targeted radioligand therapy. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets.

About the Role

Immunome is seeking a Senior Oncology Account Manager to drive territory-level sales performance in preparation for and following the potential launch of varegacestat in desmoid tumors. This role will be responsible for building strong relationships with healthcare providers, executing brand strategy at the local level, and ensuring that patients and physicians in the territory have the information and support needed to consider varegacestat as a treatment option. This work is grounded in authentic patient centricity, keeping the needs of people living with desmoid tumors at the center of every decision. As a core member of the U.S. Commercial organization, this individual will partner cross-functionally with Market Development, Marketing, Market Access, and Medical Affairs to deliver a compliant, insight-driven customer experience. The mission of this role is to achieve territory sales objectives while establishing Immunome as a trusted commercial and scientific partner